Alessandra Cesano

NanoString Technologies has named Alessandra Cesano its chief medical officer. Cesano brings more than 25 years of experience in drug development, diagnostics, and cancer immunology.

Cesano comes to NanoString from Cleave Biosciences where she served as CMO. She was also CMO and chief operations officer at Nodality. Prior to Nodality, she held various management positions at Biogen Idec, Amgen, and SmithKline Beecham Pharmaceuticals, and positions in academia and tumor immunology research.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.